Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: J Neurooncol. 2021 Aug 19;154(2):257–263. doi: 10.1007/s11060-021-03826-3

Table 2.

Means, standard deviations, and correlations among study

1 2 3 4
1. Depression
2. Anxiety .68*
3. Pain intensity .40* .29*
4. Pain interference .44* .30* .74*
Descriptives
Full sample (N = 214)
 Scale 0–27 0–21 0–100 8–40
M 10.58 9.30 51.65 22.59
SD 5.55 5.70 24.38 10.06
NF1 (n = 154)
M 10.84 9.54 51.62 21.70
SD 5.37 5.59 24.39 9.87
NF2 (n = 31)
M 8.43 7.85 43.23 21.06
SD 4.88 5.57 20.27 8.99
SCHWN (n = 29)
M 11.41 9.55 60.80 28.79
SD 6.70 6.31 25.80 10.15

Levels of depression anxiety were similar between the initial sample (N = 228, PHQ-9: M = 10.70, SD = 5.84; GAD-7: M = 9.44, SD = 5.78) and the final sample (N = 214, PHQ-9: M = 10.58, SD = 5.55; GAD-7: M = 9.30, SD = 5.70), containing only participants who endorsed pain intensity scores above 0

Depression = PHQ-9. Anxiety = GAD-7. Pain Intensity = GCPS Pain Intensity subscale. Pain Interference = PROMIS – PI8

*

p < .01